Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Share-based Compensation (2023 - 2025)

Rallybio (RLYB) has disclosed Share-based Compensation for 3 consecutive years, with $774000.0 as the latest value for Q4 2025.

  • Quarterly Share-based Compensation fell 60.57% to $774000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.3 million through Dec 2025, down 33.52% year-over-year, with the annual reading at $5.3 million for FY2025, 33.52% down from the prior year.
  • Share-based Compensation hit $774000.0 in Q4 2025 for Rallybio, down from $1.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $3.0 million in Q1 2023 to a low of $774000.0 in Q4 2025.
  • Historically, Share-based Compensation has averaged $2.0 million across 3 years, with a median of $2.0 million in 2024.
  • Biggest YoY gain for Share-based Compensation was 10.01% in 2025; the steepest drop was 60.57% in 2025.
  • Year by year, Share-based Compensation stood at $2.5 million in 2023, then fell by 22.99% to $2.0 million in 2024, then plummeted by 60.57% to $774000.0 in 2025.
  • Business Quant data shows Share-based Compensation for RLYB at $774000.0 in Q4 2025, $1.0 million in Q3 2025, and $1.6 million in Q2 2025.